Tpl2-IN-34

CAS No. 915363-56-3

Tpl2-IN-34( Tpl2 inhibitor 34 | MAP3K8-IN-34 )

Catalog No. M16575 CAS No. 915363-56-3

A potent, selective Tpl2 (cot/MAP3K8) inhibitor with IC50 of 1.6 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 123 Get Quote
5MG 204 Get Quote
10MG 330 Get Quote
25MG 681 Get Quote
50MG 1197 Get Quote
100MG 1971 Get Quote
500MG 3942 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Tpl2-IN-34
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective Tpl2 (cot/MAP3K8) inhibitor with IC50 of 1.6 nM.
  • Description
    A potent, selective Tpl2 (cot/MAP3K8) inhibitor with IC50 of 1.6 nM; dispalys 6875-fold selectivity over EGFR. P38, Src, CAMKII, MK2, PKA, and PKC (IC50>10 uM); inhibits LPS-induced TNF-α production in whole blood with IC50 of 0.3 uM; shows good efficacy in inhibiting TNF-alpha production in a LPS-stimulated rat inflammation model; orally active.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Tpl2 inhibitor 34 | MAP3K8-IN-34
  • Pathway
    MAPK/ERK Signaling
  • Target
    MEK
  • Recptor
    MEK
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    915363-56-3
  • Formula Weight
    539.4347
  • Molecular Formula
    C26H25Cl2FN8
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CCN1CCC(CC1)N2C=C(N=N2)CNC3=CC4=C(C(=CN=C4C(=C3)Cl)C#N)NC5=CC(=C(C=C5)F)Cl
  • Chemical Name
    3-Quinolinecarbonitrile, 8-chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-[[[1-(1-ethyl-4-piperidinyl)-1H-1,2,3-triazol-4-yl]methyl]amino]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wu J, et al. Bioorg Med Chem Lett. 2009 Jul 1;19(13):3485-8.
molnova catalog
related products
  • Selonsertib

    Selonsertib (GS-4997)?is a highly selective and potent, ATP-competetive inhibitor of ASK1 (Apoptosis Signal-regulating Kinase 1,?MAP3K5) with potential anti-inflammatory, antineoplastic and anti-fibrotic activities; orally bioavailable.

  • MAP3K14-IN-173

    A novel potent MAP3K14 kinase inhibitor with IC50 of 1.8 nM (NIK autophosphorylation).

  • Etacrynic acid

    A loop diuretic used to treat high blood pressure and the swelling, a novel ligand and inhibitor of MAP2K6 kinase that inhibits MAP2K6 in part through alkylation of a nonconserved cysteine residue.